Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.13 USD | +3.90% | +5.45% | -36.61% |
Business Summary
Number of employees: 330
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Cell and Gene Therapies
100.0
%
| 130 | 100.0 % | 65 | 100.0 % | -50.42% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 130 | 100.0 % | 65 | 100.0 % | -50.42% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Kristin Yarema
CEO | Chief Executive Officer | 53 | 01/23/01 |
Johanna Mylet
DFI | Director of Finance/CFO | 37 | 01/15/01 |
Mark Gergen
CHM | Chairman | 61 | 01/18/01 |
Loren Wagner
COO | Chief Operating Officer | - | 01/21/01 |
Chief Tech/Sci/R&D Officer | - | - | |
Kristin Martin
ADM | Chief Administrative Officer | 49 | 01/19/01 |
Harry Leonhardt
CMP | Compliance Officer | 67 | 16/20/16 |
Sarah Thailing
IRO | Public Communications Contact | - | 01/20/01 |
Lisa Portale
LAW | General Counsel | - | 01/19/01 |
Karen Basbaum
PRN | Corporate Officer/Principal | - | 01/20/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Marcea Lloyd
BRD | Director/Board Member | 75 | 01/19/01 |
Cynthia Collins
BRD | Director/Board Member | 65 | 23/21/23 |
Mark Gergen
CHM | Chairman | 61 | 01/18/01 |
John Schmid
BRD | Director/Board Member | 60 | 19/18/19 |
Charles Baum
BRD | Director/Board Member | 65 | 16/22/16 |
Rafael Amado
BRD | Director/Board Member | 60 | 13/23/13 |
Kristin Yarema
CEO | Chief Executive Officer | 53 | 01/23/01 |
Luke Corning
BRD | Director/Board Member | 41 | 16/20/16 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 96,489,127 | 63,182,205 ( 65.48 %) | 0 | 65.48 % |
Company contact information
Poseida Therapeutics, Inc.
9390 Towne Centre Drive Suite 200
92121, San Diego
+858 779 3100
http://www.poseida.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-36.61% | 206M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+0.52% | 22.15B | |
-17.37% | 21.02B | |
-8.77% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- PSTX Stock
- Company Poseida Therapeutics, Inc.